NEULAND LABORATORIES
|
The Current P/S Ratio of NEULAND LABORATORIES is 11.35.
| Share Price | ₹17,937.6 | Jun 25,2026 |
| Market Cap | ₹22,960.1 Cr | |
| Sales-TTM | ₹2,023.0 Cr | TTM-Consolidated Results |
| Price/Sales | 11.35x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of NEULAND LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹22,960.1 Cr] as on Jun 25,2026
(/) Sales [ ₹2,023.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 11.35x ]
Thus, for NEULAND LABORATORIES , the investors are currently willing to pay '11.35 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of NEULAND LABORATORIES !
The chart below summarizes the trend in P/S Ratio of NEULAND LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of NEULAND LABORATORIES
PS Ratio Performance Analysis for NEULAND LABORATORIES
- NEULAND LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 4.37x.
- NEULAND LABORATORIES 's operated at median p/e ratio of 2.86x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NEULAND LABORATORIES 's p/e ratio peaked in Mar2025 at 10.49x.
- NEULAND LABORATORIES 's p/e ratio hit its five-year low in Mar2022 of 1.38x.
How does NEULAND LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| NEULAND LABORATORIES | 2,023.0 | 11.35 | 22,960.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.64 | 446,792.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.87 | 178,152.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 10.94 | 152,915.0 |
| CIPLA LTD | 28,162.6 | 4.13 | 116,354.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.34 | 112,681.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.12 | 101,632.0 |
| LUPIN LTD | 27,958.0 | 3.83 | 107,091.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.05 | 109,875.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.66 | 89,468.4 |
| LAURUS LABS LTD | 6,812.9 | 11.50 | 78,368.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NEULAND LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.66x |
| Max industry PS | 16.87x |
| Median industry PS | 7.12x |
| Average industry PS | 7.58x |
You may also like the below Video Courses